Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.56)
# 2,120
Out of 4,873 analysts
27
Total ratings
60%
Success rate
11.73%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $9.55 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $285.97 | +20.29% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $13.72 | +289.94% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $37.26 | +7.35% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $13.60 | +120.59% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $3.63 | +134.16% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $9.44 | +69.49% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.06 | +34,900.00% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.17 | +13,072.97% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.23 | +1,478.95% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $7.07 | +126.31% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $2.89 | +1,457.09% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.55
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $285.97
Upside: +20.29%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $13.72
Upside: +289.94%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $37.26
Upside: +7.35%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $13.60
Upside: +120.59%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $3.63
Upside: +134.16%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $9.44
Upside: +69.49%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.06
Upside: +34,900.00%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.17
Upside: +13,072.97%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.23
Upside: +1,478.95%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $7.07
Upside: +126.31%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $2.89
Upside: +1,457.09%